(BUSINESS WIRE)-- Covidien plc (NYSE: COV) will report first-quarter results on January 26, 2012, before trading begins. The Company will hold a conference call for investors at 8:30 a.m. ET. The call can be accessed in the following ways:
At Covidien’s website: http://investor.covidien.com
By telephone: For both “listen-only” participants and those participants who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 866-383-8119. For participants outside the U.S., the dial-in number is 617-597-5344. The access code for all callers is 67436141.
Through an audio replay: A replay of the conference call will be available beginning at 11:30 a.m. on January 26, 2012, and ending at 5:00 p.m. on February 2, 2012. The dial-in number for U.S. participants is 888-286-8010. For participants outside the U.S., the replay dial-in number is 617-801-6888. The replay access code for all callers is 83053610.
ABOUT COVIDIEN
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2011 revenue of $11.6 billion, Covidien has 41,000 employees worldwide in more than 65 countries, and its products are sold in over 140 countries. Please visit www.covidien.comto learn more about our business.
Contacts
Covidien plc
Eric Kraus, 508-261-8305
Senior Vice President, Corporate Communications
eric.kraus@covidien.com
Bruce Farmer, 508-452-4372
Vice President, Public Relations
bruce.farmer@covidien.com
Coleman Lannum, CFA, 508-452-4343
Vice President, Investor Relations
cole.lannum@covidien.com
Todd Carpenter, 508-452-4363
Director, Investor Relations
todd.carpenter@covidien.com
No comments:
Post a Comment